← Back to Screener
OptimizeRx Corporation Common Stock (OPRX)
Price$6.64
Favorite Metrics
Price vs S&P 500 (26W)-68.90%
Price vs S&P 500 (4W)-4.40%
Market Capitalization$120.08M
P/E Ratio (Annual)23.40x
All Metrics
P/CF (Annual)6.42x
Book Value / Share (Quarterly)$6.84
P/TBV (Annual)2.61x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)20.56%
Cash Flow / Share (Quarterly)$1.00
Price vs S&P 500 (YTD)-50.44%
Gross Margin (TTM)67.25%
Net Profit Margin (TTM)4.69%
EPS (TTM)$0.27
10-Day Avg Trading Volume0.44M
EPS Excl Extra (TTM)$0.27
Revenue Growth (5Y)20.37%
EPS (Annual)$0.27
ROI (Annual)3.33%
Gross Margin (Annual)67.25%
Net Profit Margin (5Y Avg)-11.88%
Cash / Share (Quarterly)$1.25
P/E Basic Excl Extra (TTM)23.40x
Revenue Growth QoQ (YoY)-0.24%
P/E Normalized (Annual)23.40x
ROA (Last FY)2.90%
Revenue Growth TTM (YoY)18.78%
EBITD / Share (TTM)$1.38
ROE (5Y Avg)-7.17%
Operating Margin (TTM)10.69%
Cash Flow / Share (Annual)$1.00
P/B Ratio0.94x
P/B Ratio (Quarterly)1.78x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.12x
Net Interest Coverage (TTM)2.41x
ROA (TTM)3.00%
EV / EBITDA (TTM)4.67x
EPS Incl Extra (Annual)$0.27
Current Ratio (Annual)3.04x
Quick Ratio (Quarterly)2.91x
3-Month Avg Trading Volume0.41M
52-Week Price Return-23.17%
EV / Free Cash Flow (Annual)6.52x
P/E Incl Extra (TTM)23.40x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$4.66
P/S Ratio (Annual)1.10x
Asset Turnover (Annual)0.62x
52-Week High$22.25
Operating Margin (5Y Avg)-12.04%
EPS Excl Extra (Annual)$0.27
CapEx CAGR (5Y)-22.31%
Tangible BV CAGR (5Y)18.28%
26-Week Price Return-64.91%
Quick Ratio (Annual)2.91x
13-Week Price Return-54.48%
Total Debt / Equity (Annual)0.20x
Current Ratio (Quarterly)3.04x
Enterprise Value$122.389
Revenue / Share Growth (5Y)14.55%
Asset Turnover (TTM)0.64x
Book Value / Share Growth (5Y)15.81%
Revenue / Employee (Annual)$1
Pretax Margin (Annual)6.35%
Cash / Share (Annual)$1.25
3-Month Return Std Dev76.53%
Gross Margin (5Y Avg)62.45%
Net Income / Employee (TTM)$0
EBITDA Interim CAGR (5Y)60.17%
ROE (Last FY)4.00%
Net Interest Coverage (Annual)2.41x
EPS Basic Excl Extra (Annual)$0.27
P/FCF (TTM)6.39x
Receivables Turnover (TTM)2.88x
EV / Free Cash Flow (TTM)6.52x
Total Debt / Equity (Quarterly)0.20x
EPS Incl Extra (TTM)$0.27
Receivables Turnover (Annual)2.88x
ROI (TTM)3.42%
P/S Ratio (TTM)1.10x
Pretax Margin (5Y Avg)-13.51%
Revenue / Share (Annual)$5.76
Tangible BV / Share (Annual)$4.66
Forward P/E7.05x
Price vs S&P 500 (52W)-53.00%
P/E Ratio (TTM)23.40x
Year-to-Date Return-47.80%
5-Day Price Return3.90%
EPS Normalized (Annual)$0.27
ROA (5Y Avg)-5.33%
Net Profit Margin (Annual)4.69%
Month-to-Date Return1.91%
Cash Flow / Share (TTM)$-0.70
EBITD / Share (Annual)$0.85
Operating Margin (Annual)10.69%
LT Debt / Equity (Annual)0.17x
P/CF (TTM)6.42x
ROI (5Y Avg)-5.93%
P/E Excl Extra (TTM)23.40x
LT Debt / Equity (Quarterly)0.17x
EPS Basic Excl Extra (TTM)$0.27
P/TBV (Quarterly)2.61x
P/B Ratio (Annual)1.78x
Pretax Margin (TTM)6.35%
Book Value / Share (Annual)$6.84
Price vs S&P 500 (13W)-55.17%
Beta1.24x
P/FCF (Annual)6.39x
Revenue / Share (TTM)$5.78
ROE (TTM)4.22%
52-Week Low$5.54
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.15
4.15
4.15
4.15
Industry Peers — Business Services(98)
| Symbol | P/E Ratio (Annual) | Revenue Growth (5Y) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
OPRXOptimizeRx Corporation Common Stock | 23.40x | 20.37% | 10.69% | 4.22% | $6.64 |
VVISA Inc. | 29.77x | 12.86% | 59.18% | 54.22% | $315.10 |
MAMastercard Incorporated | 31.01x | 16.47% | 57.63% | 198.48% | $518.54 |
UBERUber Technologies, Inc. | 15.66x | 36.10% | 10.70% | 40.31% | $76.48 |
ACNAccenture PLC | 15.48x | 9.47% | 14.42% | 24.71% | $194.00 |
MELIMercado Libre, Inc | 47.55x | 48.70% | 11.08% | 33.73% | $1822.13 |
DASHDoorDash, Inc. Class A Common Stock | 83.60x | 36.58% | 5.27% | 10.15% | $179.33 |
RELXRELX PLC | 22.76x | 3.10% | 27.65% | 90.85% | $36.21 |
PYPLPayPal Holdings, Inc. Common Stock | 8.76x | 9.11% | 18.28% | 25.87% | $49.81 |
EBAYeBay Inc | 22.13x | 4.53% | 20.51% | 42.68% | $101.96 |
MSCIMSCI, Inc. | 34.27x | 13.08% | 54.67% | 108.67% | $564.90 |
About
OptimizeRx provides a cloud-based digital health messaging platform integrated with electronic health records that enables pharmaceutical companies to communicate directly with healthcare providers and patients. The platform supports medication adherence through real-time access to financial assistance, prior authorization, clinical information, and patient education. Its product suite includes Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.